[1]桂光明,曹波,张惠.Quadrant通道微创椎体间融合术和MIS-TLIF治疗腰椎退行性疾病的效果[J].齐鲁医学杂志,2017,32(06):728-731,735.[doi:10.13362/j.qlyx.201706028]
 GUI Guangming,CAO Bo,ZHANG Hui.EFFICACY COMPARISON OF QUADRANT CHANNEL MINIMALLY INVASIVE INTERBODY FUSION AND MINIMALLY INVASIVE TRANSFORAMINAL LUMBAR INTERBODY FUSION IN TREATMENT OF LUMBAR DEGENERATIVE DISEASE[J].Medical Journal of Qilu,2017,32(06):728-731,735.[doi:10.13362/j.qlyx.201706028]
点击复制

Quadrant通道微创椎体间融合术和MIS-TLIF治疗腰椎退行性疾病的效果()
分享到:

《齐鲁医学杂志》[ISSN:1008-0341/CN:37-1280/R]

卷:
第32卷
期数:
2017年06期
页码:
728-731,735
栏目:
出版日期:
2018-03-20

文章信息/Info

Title:
EFFICACY COMPARISON OF QUADRANT CHANNEL MINIMALLY INVASIVE INTERBODY FUSION AND MINIMALLY INVASIVE TRANSFORAMINAL LUMBAR INTERBODY FUSION IN TREATMENT OF LUMBAR DEGENERATIVE DISEASE
文章编号:
1008-0341(2017)06-0728-05
作者:
桂光明1曹波1张惠2
鄂东医疗集团黄石市中医医院(湖北理工学院附属医院),湖北 黄石 435000 1 骨科; 2 麻醉科
Author(s):
GUI Guangming CAO Bo ZHANG Hui
Department of Orthopedics, Huangshi Hospital of Traditional Chinese Medicine, Hubei Medical Group (the Affiliated Hospital of Hubei Polytechnic University), Huangshi 435000, China
关键词:
椎间盘退行性变Quadrant通道脊柱融合术微创经椎间孔腰椎椎间融合术最小侵入性外科手术
Keywords:
intervertebral disc degeneratio Quadrant channel minimally invasive transforaminal lumbar interbody fusion spinal fusion minimally invasive surgical procedures
分类号:
R681.5
DOI:
10.13362/j.qlyx.201706028
文献标志码:
A
摘要:
目的 探讨Quadrant通道微创椎体间融合术和微创经椎间孔腰椎椎间融合术(MIS-TLIF)治疗腰椎退行性疾病的效果。
方法 2015年1月—2017年1月,在我院行手术治疗的腰椎退行性疾病病人90例,随机分为试验组和对照组,各45例。试验组采用22 mm Quadrant通道行微创椎体间融合术,对照组采用MIS-TLIF。观察并比较两组手术时间、术中出血量、术后引流量、切口长度,术后1周、6个月、12个月疼痛视觉模拟(VAS)评分和Oswestry功能障碍指数(ODI)评分。
结果 试验组术中出血量、术后引流量、切口长度低于对照组,差异有统计学意义(t=1.994~2.317,P<0.05);两组手术时间比较差异无显著性(P>0.05)。试验组术后1周、6个月VAS评分、ODI评分明显低于对照组,差异有统计学意义(t=2.025~2.251,P<0.05);术前及术后12个月两组间VAS评分、ODI评分比较差异无统计学意义(P>0.05)。
结论 应用Quadrant通道微创椎体间融合术治疗腰椎退行性疾病术后早期减轻病人疼痛、改善腰椎功能效果优于MIS-TLIF,具有较大的临床应用价值。
Abstract:
Objective  To compare the efficacy between Quadrant channel minimally invasive interbody fusion and minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in the treatment of lumbar degenerative disease.
Methods From January 2015 to January 2017, 90 patients with lumbar degenerative disease who underwent surgery in our hospital were randomly and equally divided into experimental group and control group. The experimental group was treated with 22 mm Quadrant channel minimally invasive interbody fusion, while the control group was treated with MIS-TLIF. Operation time, intraoperative blood loss, postoperative drainage volume, and incision length, as well as Visual Analogue Scale (VAS) scores and Oswestry Disability Index (ODI) scores at 1 week, 6 months, and 12 months after surgery, were compared between the two groups.
Results The intraoperative blood loss, postoperative drainage volume, and incision length were significantly smaller in the experimental group than in the control group (t=1.994-2.317,P<0.05). However, there was no significant difference in operation time between the two groups (P>0.05). The VAS scores and ODI scores at one week and 6 months after surgery were significantly lower in the experimental group than in the control group (t=2.025-2.251,P<0.05). There were no significant differences in the VAS scores or ODI scores before surgery or at 12 months after surgery between the two groups (P>0.05).
Conclusion  For patients with lumbar degenerative disease, Quadrant channel minimally invasive interbody fusion is superior to MIS-TLIF in relieving pain and improving lumbar function in the early stage. Quadrant channel minimally invasive interbody fusion holds promise for clinical treatment of lumbar degenerative disease.
更新日期/Last Update: 2018-03-24